Hypereosinophilic syndrome: The hypereosinophilic syndrome (HES) is a disease characterized by a persistently elevated eosinophil count (≥ 1500 eosinophils/mm³) in the blood for at least six months without any recognizable cause, with involvement of either the heart, nervous system, or bone marrow. HES is a diagnosis of exclusion, after clonal eosinophilia (such as leukemia) and reactive eosinophilia (in response to infection, autoimmune disease, atopy, hypoadrenalism, tropical eosinophilia, or cancer) have been ruled out.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
569 |
4. Check minimum number of eventsNone |
569 |
5. Include endpointsNone |
569 |
6. Filter based on genotype QC (FinnGen only) |
569 |
Control definitions (FinnGen only)
- Control exclude
- ASTHMA_EXCL
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D72
- Name in latin
- Eosinophilia
Similar endpoints
↥List of similar endpoints to
Eosinophilic disease (BM)
based on the number of shared cases.
Similar with more cases:
- Eosinophilia
- Other disorders of white blood cells
- Other diseases of blood and blood-forming organs, wide
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Excluding asthma or asthma-COPD overlap
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3527 | 1843 | 1656 |
| Only index persons | 3164 | 1666 | 1498 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.05 | 0.05 |
| Only index persons | 0.06 | 0.06 | 0.06 |
| Median age at first event (years) | |||
| Whole population | 54.37 | 53.72 | 55.30 |
| Only index persons | 53.92 | 52.99 | 54.95 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 569 | 302 | 267 |
| Unadjusted period prevalence (%) | 0.11 | 0.10 | 0.12 |
| Median age at first event (years) | 56.84 | 52.68 | 61.55 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 501
- Matched controls
- 5020
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D72.1
ICD-10 Finland
Eosinophilia
+∞
323.0
489
*
J45.9
ICD-10 Finland
Asthma, unspecified
35.0
148.0
196
90
J45.1
ICD-10 Finland
Nonallergic asthma
511.4
124.6
119
*
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
18.7
118.0
194
163
H02AB06
ATC
prednisolone; systemic
9.0
110.6
359
1089
J45.0
ICD-10 Finland
Predominantly allergic asthma
77.1
102.1
114
19
J18.9
ICD-10 Finland
Pneumonia, unspecified
20.1
98.2
154
108
R03DC03
ATC
montelukast; oral
12.8
84.8
163
181
R03BB04
ATC
tiotropium bromide; inhalant
33.3
78.9
104
39
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
54.1
78.5
93
21
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
292.9
75.6
75
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
5.7
72.2
314
1133
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
47.9
66.9
81
20
R03AC02
ATC
salbutamol; inhalant
5.2
65.3
328
1332
J32.4
ICD-10 Finland
Chronic pansinusitis
651.0
60.0
58
*
R03AK06
ATC
salmeterol and fluticasone; inhalant
11.3
59.9
120
136
R03AK08
ATC
formoterol and beclometasone; inhalant
65.2
59.3
68
12
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
625.6
57.8
56
*
XW000
NOMESCO Finland
Bone marrow biopsy
19.9
57.3
88
53
UGC12
NOMESCO Finland
Flexible bronchoscopy
27.3
57.1
79
34
J33.0
ICD-10 Finland
Polyp of nasal cavity
111.1
55.1
59
6
R03BA05
ATC
fluticasone; inhalant
7.8
54.7
139
234
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
153.9
53.0
55
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
20.0
52.3
80
47
TDM10
NOMESCO Finland
Puncture of maxillary antrum
538.4
50.3
49
*
J45
ICD-10 Finland
Asthma
14.0
49.2
87
74
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.3
45.8
226
806
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
11.9
45.5
87
87
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
11.8
44.5
85
85
R01AD08
ATC
fluticasone; nasal
4.5
44.1
194
615
XG474
NOMESCO Finland
Exhalation nntrogen oxide
43.0
43.8
54
14
J46
ICD-10 Finland
Status asthmaticus
430.1
40.7
40
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
44.1
39.2
48
12
R03BA08
ATC
ciclesonide; inhalant
9.9
37.8
79
93
J45.8
ICD-10 Finland
Mixed asthma
108.4
37.3
40
*
R03AK07
ATC
formoterol and budesonide; inhalant
5.2
36.2
126
304
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
+∞
35.8
34
*
R01AD09
ATC
mometasone; nasal
3.4
35.6
261
1218
TGC00
NOMESCO Finland
Bronchial lavation
193.3
35.2
36
*
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
31.5
34.9
46
16
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
20.6
34.8
52
28
J82
ICD-10 Finland
Pulmonary eosinophilia, not elsewhere classified
+∞
34.8
33
*
J33.8
ICD-10 Finland
Other polyp of sinus
+∞
34.8
33
*
H02AB04
ATC
methylprednisolone; systemic
5.7
34.7
109
232
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
3.2
34.5
290
1487
R03AC12
ATC
salmeterol; inhalant
29.6
34.4
46
17
DHB20
NOMESCO Finland
Polypectomy of internal nose
348.6
33.3
33
*
H02AB07
ATC
prednisone; oral
5.7
33.1
103
216
R96
ICPC
Asthma
9.7
32.9
69
81
R50.9
ICD-10 Finland
Fever, unspecified
5.4
32.7
107
238
J01.0
ICD-10 Finland
Acute maxillary sinusitis
4.4
32.0
133
381
R03BA01
ATC
beclometasone; inhalant
6.0
31.9
94
184
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.0
31.4
110
264
XQ800
NOMESCO Finland
Prick test
8.7
31.2
70
92
J31.0
ICD-10 Finland
Chronic rhinitis
13.6
30.8
54
44
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
20.4
30.2
45
24
A02BC02
ATC
pantoprazole; systemic
3.1
30.2
348
2129
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
16.1
28.9
47
32
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
23.4
28.7
41
19
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
16.7
28.7
46
30
R06.0
ICD-10 Finland
Dyspnoea
3.9
28.5
136
437
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
+∞
28.4
27
*
J01MA14
ATC
moxifloxacin; systemic
7.6
28.4
69
103
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
8.1
28.3
66
92
R03AK11
ATC
formoterol and fluticasone; inhalant
45.3
28.1
34
8
J01MA12
ATC
levofloxacin; systemic
4.1
27.8
121
357
ZXE00
NOMESCO Finland
One hour or less
2.9
27.8
245
1234
R03AC13
ATC
formoterol; inhalant
13.8
27.7
48
38
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
4.8
27.3
100
249
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.2
26.6
173
702
R06AE07
ATC
cetirizine; oral
2.8
26.3
246
1271
R03BA02
ATC
budesonide; inhalant
4.5
26.1
102
270
XG410
NOMESCO Finland
Flow-volume spirometry
20.0
26.1
39
21
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
20.4
25.6
38
20
R01AD12
ATC
fluticasone furoate; nasal
3.1
25.4
176
744
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
5.1
25.0
85
194
R03DA04
ATC
theophylline; systemic, rectal
14.8
24.5
41
30
J01AA02
ATC
doxycycline; systemic
2.9
23.7
395
2805
WZC30
NOMESCO Finland
Teaching
4.0
23.2
101
294
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.2
23.1
76
167
J34.2
ICD-10 Finland
Deviated nasal septum
68.3
23.0
26
*
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
65.5
22.0
25
*
A02BC01
ATC
omeprazole; systemic
2.9
21.9
166
730
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
229.4
21.8
22
*
R05
ICD-10 Finland
Cough
3.4
21.7
121
429
R03AC03
ATC
terbutaline; inhalant
4.4
20.9
80
206
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
80.2
20.8
23
*
J47
ICD-10 Finland
Bronchiectasis
218.5
20.7
21
*
C03CA01
ATC
furosemide; systemic
3.0
20.3
142
589
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
9.6
20.0
41
46
DPA30
NOMESCO Finland
Sphenotomy
207.7
19.7
20
*
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.5
19.6
208
1101
R03DC01
ATC
zafirlukast; oral
35.9
19.1
24
7
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.9
18.8
134
558
J01FA06
ATC
roxithromycin; oral
2.5
18.5
200
1061
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.6
18.4
92
298
UDM02
NOMESCO Finland
Sinoscopy
45.8
18.4
22
5
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.1
18.3
117
453
ZX112
NOMESCO Finland
Subcutaneous
14.4
18.0
30
22
J01DB01
ATC
cefalexin; oral
2.6
17.7
413
3194
ZXE10
NOMESCO Finland
More than one and less than three hours
2.4
17.6
202
1096
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
186.2
17.6
18
*
N02AX02
ATC
tramadol; systemic, rectal
2.4
17.6
210
1163
H02AB09
ATC
hydrocortisone; systemic
14.6
17.5
29
21
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
10.9
17.4
33
32
JN4BD
NOMESCO Finland
Extensive body CT
3.9
17.1
74
212
E0000UV
ATC
NA
2.3
16.9
212
1200
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.0
16.8
106
406
M05BA04
ATC
alendronic acid; oral
4.8
16.8
58
134
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
+∞
16.8
16
*
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
3.0
16.7
109
426
R06AX27
ATC
desloratadine; oral
2.6
16.4
146
687
J01FA09
ATC
clarithromycin; systemic
2.4
16.2
166
845
R02
ICPC
Shortness of breath/dyspnoea
4.4
16.2
60
149
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.4
16.2
61
154
R01AD01
ATC
beclometasone; nasal
3.3
16.1
88
303
ZXA10
NOMESCO Finland
Bilateral
2.9
15.9
108
433
Z01.8
ICD-10 Finland
Other specified special examinations
2.8
15.7
116
489
Z88.6
ICD-10 Finland
Personal history of allergy to analgesic agent
+∞
15.7
15
*
D07AC01
ATC
betamethasone; topical
2.3
15.6
180
968
J01CA04
ATC
amoxicillin; systemic
2.4
15.4
399
3100
WX002
NOMESCO Finland
Sedation and analgesia
2.7
15.1
120
526
J01FF01
ATC
clindamycin; systemic
2.5
15.1
147
721
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
4.3
15.1
57
144
J01FA10
ATC
azithromycin; systemic
2.1
14.9
285
1911
DJD20
NOMESCO Finland
Plastic repair of septum of nose
58.5
14.9
17
*
GD1AD
NOMESCO Finland
Thorax CT examination
7.7
14.7
34
47
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
154.2
14.5
15
*
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
17.6
14.4
22
13
R06AE09
ATC
levocetirizine; oral
3.0
14.3
92
354
R06.2
ICD-10 Finland
Wheezing
8.4
14.3
31
39
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.2
14.1
180
1006
R01AD05
ATC
budesonide; nasal
4.5
13.9
50
120
J33.9
ICD-10 Finland
Nasal polyp, unspecified
24.6
13.9
19
8
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
3.8
13.9
61
177
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.9
13.7
93
370
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
+∞
13.6
13
*
3028
Kela drug reimbursment
Mepolizumab
+∞
13.6
13
*
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
+∞
13.6
13
*
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
16.8
13.6
21
13
A02BC05
ATC
esomeprazole; systemic
2.2
13.5
196
1151
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
4.4
13.4
49
120
UJF32
NOMESCO Finland
Coloscopy
2.4
13.2
134
664
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.3
13.2
50
127
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.2
13.0
73
256
L04AA06
ATC
mycophenolic acid; systemic
23.2
13.0
18
8
DHB50
NOMESCO Finland
Turbinoplasty
51.4
12.9
15
*
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
7.6
12.7
29
40
R03DX09
ATC
mepolizumab; parenteral
+∞
12.5
12
*
297
Kela drug reimbursment
NA
+∞
12.5
12
*
2883X
ICD-9 Finland
Diseases of white blood cells, Eosinophilia[EOSINOPHILIA, NUD]
+∞
12.5
12
*
C07AB07
ATC
bisoprolol; oral
2.0
12.3
223
1426
Z3231
NOMESCO Finland
Registered nurse
2.3
12.2
138
720
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
3.4
12.2
60
191
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
7.3
12.0
28
40
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
19.5
11.7
17
9
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
11.6
114
554
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
14.0
11.5
19
14
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
+∞
11.5
11
*
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
+∞
11.5
11
*
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
+∞
11.5
11
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
6.8
11.4
28
43
B03XA02
ATC
darbepoetin alfa; parenteral
15.5
11.4
18
12
R03BB01
ATC
ipratropium bromide; inhalant
9.9
11.3
22
23
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
4.3
11.3
42
105
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
13.1
11.2
19
15
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
11.2
103
485
R07.4
ICD-10 Finland
Chest pain, unspecified
2.2
11.1
129
677
XX3DW
NOMESCO Finland
Time consuming IT work
3.0
11.1
68
252
A07AA02
ATC
nystatin; oral
4.9
11.1
36
78
X59
ICD-10 Finland
Exposure to unspecified factor
2.5
11.0
97
445
S97
ICPC
Chronic ulcer skin
4.8
11.0
36
79
R06AX13
ATC
loratadine; oral
2.6
11.0
83
349
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
4.5
10.9
38
89
SPAT1254
SPAT
Administration of medicine
2.7
10.9
77
312
R06AX22
ATC
ebastine; oral
2.5
10.9
93
418
UDQ12
NOMESCO Finland
Flexible laryngoscopy
6.2
10.7
28
47
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.9
10.7
66
247
J30.3
ICD-10 Finland
Other allergic rhinitis
9.5
10.6
21
23
XF400
NOMESCO Finland
ECG with 12 standard connections
2.6
10.6
79
332
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
10.5
134
729
A46
ICD-10 Finland
Erysipelas
2.8
10.5
71
278
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.2
10.5
56
190
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
112.2
10.5
11
*
B01AA03
ATC
warfarin; systemic
2.4
10.4
98
464
J96.1
ICD-10 Finland
Chronic respiratory failure
+∞
10.4
10
*
D07AD01
ATC
clobetasol; topical
2.5
10.4
86
383
R53
ICD-10 Finland
Malaise and fatigue
2.5
10.3
88
397
XG405
NOMESCO Finland
Education on PEF monitoring
23.9
10.3
14
6
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
23.9
10.3
14
6
R01AD11
ATC
triamcinolone; nasal
3.3
10.2
52
170
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.9
10.0
212
1403
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
10.0
200
1295
D07AB02
ATC
hydrocortisone butyrate; topical
2.0
9.9
142
810
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
7.2
9.9
23
33
D07AC13
ATC
mometasone; topical
2.0
9.8
146
847
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
56.1
9.7
11
*
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
56.1
9.7
11
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
10.3
9.6
18
18
SPAT1263
SPAT
Sampling
1.9
9.6
205
1359
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
3.4
9.5
46
145
D64.9
ICD-10 Finland
Anaemia, unspecified
3.0
9.5
55
198
Z49.1
ICD-10 Finland
Extracorporeal dialysis
12.7
9.4
16
13
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
+∞
9.4
9
*
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
+∞
9.4
9
*
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
+∞
9.4
9
*
E000001
ATC
NA
2.2
9.3
103
525
L29.9
ICD-10 Finland
Pruritus, unspecified
6.9
9.2
22
33
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.8
9.1
60
232
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.7
9.1
30
67
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
10.3
9.1
17
17
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
3.5
9.1
41
123
DHA10
NOMESCO Finland
Biopsy of cavity of nose
37.4
9.0
11
*
ZXD05
NOMESCO Finland
Urgent procedure
1.9
9.0
147
880
A41.9
ICD-10 Finland
Sepsis, unspecified
6.3
9.0
23
38
EMB10
NOMESCO Finland
Tonsillectomy
24.5
8.9
12
5
I50.9
ICD-10 Finland
Heart failure, unspecified
3.1
8.9
50
174
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.2
8.9
33
83
D07AA02
ATC
hydrocortisone; topical
2.5
8.8
73
321
N02AJ06
ATC
codeine and paracetamol; systemic
1.9
8.8
169
1071
UJF30
NOMESCO Finland
Ileoscopy through colon
2.8
8.8
56
214
L50.9
ICD-10 Finland
Urticaria, unspecified
5.2
8.8
26
52
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
7.1
8.6
20
29
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
28.0
8.5
11
*
Z2446
NOMESCO Finland
Social worker
4.0
8.5
33
87
H65.3
ICD-10 Finland
Chronic mucoid otitis media
8.1
8.4
18
23
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
13.0
8.4
14
11
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.3
8.4
78
365
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.4
8.4
39
120
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
+∞
8.4
8
*
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
11.0
8.3
15
14
NH3EA
NOMESCO Finland
Feet X-ray examination with load
7.3
8.3
19
27
R4110
NOMESCO Finland
Physiotherapy
2.0
8.3
119
676
M05BX04
ATC
denosumab; parenteral
4.7
8.3
27
60
N05BA04
ATC
oxazepam; oral
2.0
8.2
109
600
49300
ICD-8 Finland
Asthma, bronchiale
8.3
8.1
17
21
TK800
NOMESCO Finland
Hemodialysis
8.3
8.1
17
21
L04AX01
ATC
azathioprine; systemic
4.3
8.1
29
71
L28.1
ICD-10 Finland
Prurigo nodularis
17.5
8.1
12
7
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
17.5
8.1
12
7
Z49.0
ICD-10 Finland
Preparatory care for dialysis
33.9
8.1
10
*
B01AB10
ATC
tinzaparin; parenteral
3.4
8.1
38
118
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
10.3
8.1
15
15
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
5.3
7.9
23
45
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
8.0
7.9
17
22
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.9
7.9
49
182
WW200
NOMESCO Finland
Immunization
6.3
7.9
20
33
J01DA01
ATC
[U] cefalexin; systemic
1.7
7.9
284
2172
UDC00
NOMESCO Finland
Ear microscopy
3.0
7.8
44
154
C01CA24
ATC
epinephrine; parenteral
3.8
7.8
32
89
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
3.5
7.8
35
105
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.4
7.8
36
111
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.8
7.7
152
964
R01BA52
ATC
pseudoephedrine, combinations; oral
1.9
7.7
134
814
J42
ICD-10 Finland
Unspecified chronic bronchitis
45.7
7.7
9
*
T78.4
ICD-10 Finland
Allergy, unspecified
4.3
7.7
27
65
J01FA15
ATC
telithromycin; oral
2.7
7.7
50
194
N02BE01
ATC
paracetamol; systemic, rectal
1.9
7.7
401
3418
L28
ICPC
Limited function/disability (L)
2.4
7.7
64
285
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.8
7.7
48
181
L50.3
ICD-10 Finland
Dermatographic urticaria
8.2
7.6
16
20
J37.0
ICD-10 Finland
Chronic laryngitis
18.7
7.6
11
6
7806A
ICD-9 Finland
General symptoms, Pyrexia of unknown origin
18.7
7.6
11
6
Z3226
NOMESCO Finland
Physiotherapist
2.1
7.6
86
441
R07
ICPC
Sneezing/nasal congestion
3.6
7.6
33
97
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
3.2
7.5
38
125
JN3AD
NOMESCO Finland
Abdominal CT examination
3.1
7.5
39
131
H03AA01
ATC
levothyroxine sodium; systemic
2.0
7.5
99
544
WX892
NOMESCO Finland
Monitored bed care
3.2
7.5
37
120
M81.4
ICD-10 Finland
Drug-induced osteoporosis
81.2
7.4
8
*
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
81.2
7.4
8
*
127
Kela drug reimbursment
Transplant complication
13.6
7.4
12
9
WX110
NOMESCO Finland
Local anesthesy
1.7
7.3
328
2640
M04AA01
ATC
allopurinol; systemic
2.5
7.3
59
257
3027
Kela drug reimbursment
Benralizumab
+∞
7.3
7
*
JN4AD
NOMESCO Finland
Body CT examination
3.0
7.3
41
143
N18.0
ICD-10 Finland
End-stage renal disease
16.0
7.3
11
7
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
4.9
7.2
22
46
R05
ICPC
Cough
2.0
7.2
97
535
AA1AD
NOMESCO Finland
CT of head and brain
2.0
7.2
107
611
G47.3
ICD-10 Finland
Sleep apnoea
2.0
7.2
91
490
J34.3
ICD-10 Finland
Hypertrophy of nasal turbinates
30.5
7.2
9
*
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
30.5
7.2
9
*
J35.0
ICD-10 Finland
Chronic tonsillitis
20.3
7.2
10
5
FJA10
NOMESCO Finland
Transvenous biopsy of right ventricle
20.3
7.2
10
5
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
20.3
7.2
10
5
N18.8
ICD-10 Finland
Other chronic renal failure
5.4
7.1
20
38
R06AX26
ATC
fexofenadine; oral
3.4
7.1
33
102
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
12.2
7.1
12
10
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
12.2
7.1
12
10
A01AB09
ATC
miconazole; local oral
2.9
7.1
42
154
ZX120
NOMESCO Finland
Intravenous
2.9
7.1
42
154
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
10.2
7.1
13
13
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.6
7.1
52
217
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.9
7.0
42
155
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
5.0
7.0
21
43
SPAT1262
SPAT
Handing over of treatment supplies
2.1
7.0
88
471
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.3
6.9
64
297
R11
ICD-10 Finland
Nausea and vomiting
2.9
6.9
40
144
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.9
6.9
102
583
A02BA02
ATC
ranitidine; systemic
2.1
6.9
85
452
R75
ICPC
Sinusitis acute/chronic
4.1
6.9
25
63
SPAT1058
SPAT
PEF monitoring instruction
3.1
6.8
35
117
J02AC01
ATC
fluconazole; systemic
1.7
6.8
173
1179
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
9.5
6.8
13
14
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
9.5
6.8
13
14
N02AA05
ATC
oxycodone; systemic
2.4
6.8
56
248
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.9
6.8
39
140
318
Kela drug reimbursment
Teriparatide
40.6
6.8
8
*
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
40.6
6.8
8
*
H05AA02
ATC
teriparatide; parenteral
40.6
6.8
8
*
V03AE01
ATC
polystyrene sulfonate; oral
17.0
6.8
10
6
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
6.6
6.7
16
25
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.8
6.7
133
841
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.7
6.7
21
46
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.8
6.6
40
149
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.3
6.6
31
97
S18
ICPC
Laceration/cut
1.7
6.6
194
1377
I50.0
ICD-10 Finland
Congestive heart failure
3.7
6.6
27
76
N05CF01
ATC
zopiclone; oral
1.8
6.6
129
810
SPAT1260
SPAT
Consultation of another employee
2.0
6.6
87
478
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.1
6.5
33
110
N03AX16
ATC
pregabalin; oral
1.9
6.5
97
557
J36
ICD-10 Finland
Peritonsillar abscess
70.7
6.4
7
*
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
14.5
6.4
10
7
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.5
6.4
49
210
R20.2
ICD-10 Finland
Paraesthesia of skin
3.0
6.4
34
117
A03
ICPC
Fever
2.1
6.4
70
355
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
6.7
6.4
15
23
D02AE01
ATC
carbamide; topical
2.7
6.3
41
159
L04AA01
ATC
[U] ciclosporin; systemic
9.4
6.3
12
13
R06.5
ICD-10 Finland
Mouth breathing
2.7
6.3
41
160
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
18.3
6.3
9
5
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
+∞
6.3
6
*
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
+∞
6.3
6
*
I42.3
ICD-10 Finland
Endomyocardial (eosinophilic) disease
+∞
6.3
6
*
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
+∞
6.3
6
*
B44.8
ICD-10 Finland
Other forms of aspergillosis
+∞
6.3
6
*
D86.0
ICD-10 Finland
Sarcoidosis of lung
+∞
6.3
6
*
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
+∞
6.3
6
*
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
+∞
6.3
6
*
J01.1
ICD-10 Finland
Acute frontal sinusitis
27.0
6.2
8
*
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
27.0
6.2
8
*
RK110
NOMESCO Finland
NA
27.0
6.2
8
*
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
27.0
6.2
8
*
A11CC03
ATC
alfacalcidol; systemic
6.4
6.2
15
24
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
5.5
6.2
17
32
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.2
6.2
30
97
Z2221
NOMESCO Finland
Medical doctor
1.8
6.2
123
776
P01AB01
ATC
metronidazole; oral, rectal
1.7
6.1
172
1201
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.6
6.1
43
175
R13
ICD-10 Finland
Dysphagia
3.2
6.1
29
93
XF600
NOMESCO Finland
Bloodpressure measurement
3.1
6.0
31
105
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3005322) IgE [Units/volume] in Serum or Plasma
246
125
33.95
307.65
2.8
1.1
u/ml
634.2
87.8
3.78
237
111
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
146
91
21.25
178.61
2.0
1.5
titre
92.0
97.1
—
10
7
(3003327) Ova and parasites identified in Stool by Light microscopy
131
125
13.32
124.52
2.2
1.7
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
99
59
20.11
122.25
1.6
1.3
mg/l
11.5
10.8
0.24
91
48
(3024980) IgG subclass 4 [Mass/volume] in Serum
89
46
22.76
117.05
2.0
1.3
g/l
1.7
0.6
2.86
66
34
(42870588) Differential panel, method unspecified - Blood
368
1194
6.91
115.51
12.6
5.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
120
113
13.20
114.69
1.6
1.2
u/l
43.2
40.9
0.35
111
93
(3005719) IgG [Mass/volume] in Serum or Plasma
170
273
8.46
108.05
3.2
2.2
g/l
10.4
10.7
0.29
155
248
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
82
44
21.61
105.86
1.8
1.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
87
56
18.16
103.02
3.9
2.9
e9/l
4.9
3.8
2.52
87
56
(3022096) Basophils/100 leukocytes in Blood
429
1721
7.10
102.63
14.0
5.0
%
0.8
0.7
5.08
417
1586
(3006504) Eosinophils/100 leukocytes in Blood
437
1787
7.27
102.15
14.1
4.9
%
6.9
2.8
24.99
424
1644
(3019069) Monocytes/100 leukocytes in Blood
437
1797
7.21
101.17
14.3
5.1
%
8.5
8.7
0.75
425
1665
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
87
59
17.23
100.24
4.2
3.3
%
56.2
56.2
0.00
87
59
(3006315) Basophils [#/volume] in Blood
452
1930
7.57
99.84
13.8
4.9
e9/l
0.1
0.0
12.57
431
1657
(3002030) Lymphocytes/100 leukocytes in Blood
442
1854
7.24
99.46
14.1
5.0
%
25.2
29.2
13.33
428
1708
(3001604) Monocytes [#/volume] in Blood
449
1920
7.39
98.52
13.8
4.9
e9/l
0.6
0.6
12.81
427
1641
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
187
370
7.04
97.02
4.1
3.9
u/l
257.5
260.3
0.03
181
348
(3021440) Promyelocytes/100 leukocytes in Blood
162
276
7.81
96.94
5.6
4.1
%
0.1
0.2
1.07
60
73
(3013115) Eosinophils [#/volume] in Blood
456
1995
7.52
96.92
14.9
5.2
e9/l
0.5
0.2
27.50
434
1743
(3017181) Myelocytes/100 leukocytes in Blood
165
287
7.69
96.86
5.7
4.1
%
0.5
0.9
0.94
62
80
(3018010) Neutrophils/100 leukocytes in Blood
435
1829
6.89
96.60
13.2
4.8
%
55.2
56.3
0.91
421
1698
(3019198) Lymphocytes [#/volume] in Blood
453
1990
7.30
95.17
13.8
4.9
e9/l
1.9
2.0
0.38
433
1746
(3002179) Metamyelocytes/100 leukocytes in Blood
156
264
7.77
93.72
5.4
3.9
%
0.4
0.4
0.12
54
58
(3028026) IgM [Mass/volume] in Serum or Plasma
141
220
8.20
90.98
1.7
1.6
g/l
1.1
1.4
0.93
129
204
(3025159) Blasts/100 leukocytes in Blood
149
260
7.41
86.58
5.9
4.2
%
0.1
0.1
0.33
53
64
(3037522) Nuclear Ab [Titer] in Serum
203
499
5.77
82.48
1.5
1.3
titre
524.8
458.6
0.20
50
103
(21494434) Karyotype in Bone marrow
62
31
22.33
82.08
1.1
1.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
156
305
6.67
80.78
3.1
2.1
nmol/l
316.9
364.6
2.37
151
286
(3028192) IgG subclass 2 [Mass/volume] in Serum
53
25
23.28
71.69
1.6
1.2
g/l
3.0
2.5
0.76
37
13
(3024139) IgG subclass 3 [Mass/volume] in Serum
53
25
23.28
71.69
1.6
1.2
g/l
0.4
0.6
0.59
38
13
(3027135) IgG subclass 1 [Mass/volume] in Serum
53
25
23.28
71.69
1.6
1.2
g/l
6.9
9.9
0.64
38
13
(4062490)
53
26
22.38
70.53
1.6
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
454
2318
5.78
70.53
15.9
7.5
e9/l
4.5
3.9
5.24
439
2004
(3042111) Morphology [Interpretation] in Bone marrow Narrative
65
53
13.72
66.96
1.2
1.9
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
256
909
4.31
63.36
9.9
3.9
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
162
416
5.05
60.78
2.6
2.6
%
1.8
1.8
0.01
146
370
(3004588) Protein electrophoresis panel - Serum or Plasma
118
231
6.19
59.98
2.2
2.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
162
421
4.98
59.83
2.0
1.6
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
124
267
5.66
56.76
2.2
2.3
g/l
65.3
66.9
1.28
112
237
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
42
21
21.52
55.21
1.4
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
234
855
3.95
54.15
7.1
3.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
54
48
12.33
52.51
1.1
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
53
48
12.08
50.90
2.1
2.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
126
311
4.92
48.83
2.5
2.5
e9/l
65.0
68.5
0.61
98
246
(3007164) IgA [Mass/volume] in Serum or Plasma
214
784
3.78
48.50
1.8
1.3
g/l
2.2
2.4
1.05
161
492
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
388
2079
3.73
48.16
7.0
5.4
umol/l
10.0
11.9
3.92
381
1963
(46235355) HIV 1 and 2 tests - Meaningful Use set
200
710
3.80
47.35
1.8
1.9
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
161
492
4.17
47.22
3.5
2.3
%
22.6
24.3
0.78
137
423
(3018418) pH of Serum or Plasma
267
1144
3.52
47.22
6.4
3.3
ph
7.4
7.4
0.79
88
209
(3021589) Normoblasts [#/volume] in Blood
365
1897
3.59
47.21
18.8
7.6
e9/l
0.0
0.0
0.56
327
1571
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
45
36
13.49
46.58
1.7
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
115
278
4.93
45.53
1.8
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
115
279
4.91
45.32
1.9
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
38
24
16.90
44.71
1.5
1.0
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
38
24
16.90
44.71
1.5
1.0
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
163
532
3.89
43.20
3.4
2.3
g/l
2.3
2.3
0.86
153
490
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
39
28
14.88
42.88
1.7
1.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
35
21
17.70
42.19
1.3
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
35
21
17.70
42.19
1.3
1.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
49
52
10.22
42.12
5.6
2.9
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
361
1949
3.34
42.11
10.0
5.5
mmol/l
1.2
1.2
0.55
272
1633
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
339
1764
3.29
42.11
9.0
4.8
mmol/l
1.2
1.2
0.36
314
1587
(3000850) Epithelial cells [#/volume] in Urine
207
804
3.48
41.95
3.2
2.2
e6/l
4.6
4.3
0.15
186
701
(3013707) Erythrocyte sedimentation rate by Westergren method
483
3140
4.60
41.72
8.1
3.4
mm/h
14.5
10.5
5.87
459
2863
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
42
37
12.18
40.90
1.7
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
30
14
22.57
40.33
1.8
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
127
367
4.17
39.67
4.9
2.9
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
30
15
21.06
39.19
4.0
1.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
318
1644
3.12
39.01
6.1
4.4
g/l
33.5
36.2
11.58
291
1535
(3012095) Magnesium [Moles/volume] in Serum or Plasma
159
549
3.63
38.31
3.3
3.2
mmol/l
0.8
0.8
1.59
148
518
(3026782) Osmolality of Urine
190
740
3.36
37.78
3.2
2.4
mosm/kgh2o
560.1
579.8
0.56
170
629
(40760888) Immunoglobulin light chains.free panel - Serum
53
72
8.02
37.51
2.4
2.9
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
31
19
17.20
36.89
1.6
2.5
e9/l
1.2
1.0
—
14
10
(3003458) Phosphate [Moles/volume] in Serum or Plasma
139
450
3.77
36.75
8.0
5.3
mmol/l
1.1
1.0
1.75
131
424
(3012501) Base excess in Blood by calculation
50
65
8.34
36.69
6.6
2.6
mmol/l
2.4
2.4
0.02
35
39
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
488
3317
4.35
36.61
11.8
6.1
u/l
76.9
79.7
0.82
474
3085
(3022948) Iron [Moles/volume] in Serum or Plasma
163
588
3.49
36.51
3.5
2.3
umol/l
12.2
13.9
2.26
152
540
(3007853) Bacteria identified in Skin by Aerobe culture
132
418
3.81
36.00
2.2
1.5
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
69
130
5.90
35.86
1.3
1.3
u/ml
0.2
1.4
—
7
7
(3034860) Kappa light chains.free [Mass/volume] in Serum
61
102
6.58
35.74
2.5
2.5
mg/l
44.1
36.0
0.65
39
88
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
61
102
6.58
35.74
2.5
2.5
mg/l
35.7
26.6
0.70
39
90
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
131
415
3.80
35.68
5.0
2.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
224
999
3.05
34.90
3.9
2.5
ng/l
2214.2
1015.2
1.02
201
855
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
62
109
6.26
34.56
1.8
1.9
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
132
430
3.70
34.41
1.7
1.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
306
1629
2.90
34.23
13.7
8.1
inr
1.3
1.3
0.26
143
477
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
288
1486
2.90
34.15
5.4
2.9
ng/l
41.5
64.1
0.41
208
1019
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
314
1704
2.88
33.71
2.9
2.1
nmol/l
77.9
77.7
0.04
294
1525
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
24
10
25.01
33.55
1.4
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
29
20
15.23
32.43
1.8
1.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
62
117
5.83
32.09
2.4
1.5
g/l
7.4
7.4
0.02
42
90
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
62
117
5.83
32.09
2.4
1.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
62
117
5.83
32.09
2.4
1.5
g/l
3.7
3.7
0.08
40
85
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
107
319
3.90
31.58
5.1
3.2
mmol/l
1.2
1.2
0.36
95
267
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
24
12
20.84
31.21
1.9
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
32
28
12.05
31.17
1.6
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
224
1056
2.85
30.80
3.6
2.7
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
244
1203
2.80
30.79
3.9
2.8
e6/l
15.3
66.1
3.09
209
900
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29
22
13.84
30.75
1.7
1.3
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
40
49
8.71
30.71
4.4
4.3
%
0.8
1.4
0.81
34
44
(40767503) Oxygen content in Capillary blood by calculation
42
56
8.02
30.10
2.8
1.7
%
16.6
17.5
0.39
23
26
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
58
110
5.76
29.82
2.3
1.5
g/l
3.3
3.1
0.42
41
87
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
58
111
5.71
29.53
2.4
1.4
g/l
10.2
10.5
0.10
44
93
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
273
1452
2.69
29.32
4.0
2.9
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
227
1105
2.76
29.01
3.7
2.7
e6/l
0.2
0.4
2.40
194
821
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
25
16
16.30
28.99
1.2
1.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
379
2405
2.73
27.92
6.7
3.6
mmol/l
6.7
6.6
0.27
363
2232
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
45
72
6.70
27.39
1.2
1.4
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
52
97
5.80
27.16
2.4
1.5
g/l
0.5
0.9
0.39
43
84
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
50
90
6.00
27.10
2.5
1.4
g/l
0.0
0.0
0.00
42
80
(3020779) Urea [Moles/volume] in Serum or Plasma
94
284
3.77
27.01
10.4
7.2
mmol/l
11.5
9.1
2.18
88
274
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
64
146
4.81
26.67
1.6
2.0
g/l
1.6
1.5
0.16
53
124
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
22
13
17.56
26.47
1.5
2.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
126
467
3.18
26.22
2.3
2.4
ug/g
146.3
122.9
0.21
107
374
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
148
606
2.95
25.83
1.8
1.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
265
1456
2.54
25.73
4.4
3.1
e6/l
66.3
148.6
0.79
221
989
(3015377) Calcium [Moles/volume] in Serum or Plasma
251
1348
2.54
25.54
2.9
2.9
mmol/l
2.3
2.4
5.16
226
1184
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
22
14
16.31
25.52
1.3
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
128
486
3.11
25.51
2.2
1.9
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
231
1197
2.57
25.30
3.0
2.3
u/l
55.4
59.0
0.74
218
1104
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
27
25
11.29
25.28
1.6
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
53
108
5.31
25.14
1.3
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
43
72
6.38
25.03
2.0
1.8
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
20
11
18.81
24.83
1.7
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
191
916
2.63
24.41
1.5
1.3
u/ml
0.6
1.5
2.06
55
257
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
24
20
12.49
23.98
1.7
1.2
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
46
86
5.73
23.93
2.5
1.3
g/l
0.0
0.0
0.00
38
76
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
42
72
6.22
23.87
1.4
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
88
276
3.59
23.80
1.4
1.4
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
45
83
5.80
23.74
2.6
1.3
g/l
0.0
0.0
0.00
38
75
(3028271) Lactate [Moles/volume] in Capillary blood
32
41
8.21
23.62
2.6
1.4
mmol/l
1.7
1.6
0.21
32
41
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
75
212
3.92
23.60
2.1
1.7
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
42
74
6.05
23.22
1.4
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
48
96
5.37
23.22
2.5
1.3
g/l
36.2
37.6
0.69
38
80
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
33
45
7.72
23.13
1.3
1.0
u/ml
0.4
1.8
0.44
19
12
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
225
1192
2.47
23.06
3.2
1.9
u/l
141.8
241.2
0.89
211
1110
(3000492) Spirometry study
88
282
3.51
23.00
1.8
1.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
20
13
15.91
22.89
1.5
2.6
%
9.4
17.5
—
10
8
(3010726) Horse dander IgE Ab [Units/volume] in Serum
30
37
8.50
22.83
1.2
1.0
u/ml
0.8
1.6
—
7
7
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
39
65
6.37
22.78
1.2
1.4
u/ml
242.9
242.9
0.00
26
38
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
35
52
7.11
22.76
1.9
2.1
pg
33.0
32.8
0.08
35
52
(40758558) Short blood count panel - Blood
199
1006
2.51
22.48
11.6
5.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
132
548
2.84
22.15
1.3
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
100
357
3.19
21.93
2.1
2.3
g/l
0.2
0.2
0.33
93
334
(4010399)
62
161
4.20
21.86
1.9
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
37
61
6.42
21.83
1.0
1.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
63
166
4.14
21.78
1.6
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
149
664
2.69
21.76
1.3
1.2
iu/ml
40.1
35.3
0.17
48
228
(3022806) Fractional oxyhemoglobin in Capillary blood
29
37
8.21
21.46
3.0
1.8
%
89.6
91.1
0.71
29
37
(3021901) Oxygen saturation in Capillary blood
31
43
7.57
21.39
2.5
1.8
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
237
1320
2.37
21.35
3.8
3.1
u/l
41.6
33.7
0.34
226
1267
(3026493) Urate [Moles/volume] in Serum or Plasma
199
1028
2.44
21.23
3.2
2.4
umol/l
1604.3
6970.5
2.01
183
897
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
19
13
15.09
21.15
1.4
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
50
113
4.76
20.99
1.7
1.5
iu/ml
0.0
0.1
—
7
19
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
192
986
2.43
20.66
3.1
2.1
mg/l
3.0
2.9
0.04
168
822
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
20
16
12.92
20.41
2.0
2.1
u/ml
915.8
3172.4
0.77
20
16
(3000093) Morphology [Interpretation] in Blood Narrative
24
26
9.59
20.11
1.0
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
415
2982
2.45
20.00
5.6
3.7
—
—
—
0
0
(4035726)
90
322
3.13
19.56
1.5
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
162
789
2.47
19.42
2.0
1.6
mg/l
1.4
1.2
0.37
127
614
(3001122) Ferritin [Mass/volume] in Serum or Plasma
293
1847
2.21
18.98
4.4
2.6
ug/l
149.6
132.6
0.45
272
1696
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
36
67
5.67
18.78
1.4
1.4
u/ml
120.1
98.9
—
7
8
(44813793)
21
21
10.35
18.58
1.1
1.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
213
1195
2.25
18.25
4.3
2.8
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
187
994
2.31
18.23
5.5
3.2
%
87.3
90.4
0.85
179
972
(3016650) Hepatitis A virus Ab [Presence] in Serum
35
66
5.59
18.00
1.0
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
35
66
5.59
18.00
1.4
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
27
39
7.22
17.96
1.2
1.0
u/ml
1.3
2.5
0.30
15
14
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
40
87
4.87
17.55
1.5
1.7
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
25
34
7.65
17.51
5.4
3.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
207
1171
2.21
17.18
5.0
3.5
estimate
0.0
0.0
0.50
115
377
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
144
699
2.42
17.15
5.7
3.1
ng/l
347.2
473.3
0.27
118
531
(3008401) Mugwort IgE Ab [Units/volume] in Serum
25
35
7.43
17.08
1.2
1.1
u/ml
0.4
5.7
—
13
9
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
58
173
3.62
16.77
4.1
3.1
mmol/l
1.8
0.8
1.72
45
125
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
43
104
4.39
16.57
1.2
1.3
u/ml
6.9
2.0
—
7
11
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
532
4473
3.99
16.47
28.3
9.9
mg/l
20.6
22.8
0.99
476
3287
(3014133) Dog dander IgE Ab [Units/volume] in Serum
25
37
7.02
16.26
1.2
1.0
u/ml
7.0
1.1
—
10
9
(3009261) Glucose [Presence] in Urine by Test strip
318
2153
2.08
16.20
4.4
3.2
estimate
0.0
0.0
0.80
112
370
(3022145) Colonoscopy Study observation
107
463
2.62
16.19
1.3
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
43
106
4.31
16.17
1.3
1.3
u/ml
8.7
11.3
—
8
20
(3009343) pH of Capillary blood
58
180
3.47
15.78
4.2
3.1
ph
7.4
7.4
1.03
21
20
(3021601) Nitrite [Presence] in Urine by Test strip
314
2129
2.06
15.78
5.5
4.4
estimate
0.0
0.0
0.00
121
385
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
134
653
2.38
15.68
1.3
1.2
u/ml
13.6
14.6
0.05
43
271
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
24
36
6.92
15.41
1.0
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
43
110
4.15
15.41
1.5
1.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
16
14
11.73
15.37
1.3
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
312
2132
2.03
15.10
4.5
3.3
estimate
0.0
0.0
0.00
120
387
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
99
427
2.60
15.02
3.5
2.9
umol/l
7.5
7.8
0.04
78
374
(3000991) Gas panel - Venous blood
75
280
2.93
15.00
13.4
6.4
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
21
28
7.75
14.92
1.2
1.2
u/l
43.4
54.6
0.71
14
18
(3000494) Fungus identified in Specimen by Culture
102
454
2.52
14.47
1.7
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
20
9
22.97
14.30
1.7
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
20
9
22.97
14.30
1.7
1.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
375
2770
2.04
14.20
5.3
3.9
e6/l
95.3
3645.6
—
8
37
(3023430) Cat dander IgE Ab [Units/volume] in Serum
22
33
6.89
14.12
1.2
1.0
u/ml
1.4
2.7
—
7
9
(3002032) Base excess in Venous blood by calculation
80
323
2.72
13.80
5.2
3.0
mmol/l
1.3
1.5
0.14
63
251
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
18
22
8.42
13.70
1.6
2.3
e6/l
681.4
838.0
—
10
7
(3018677) aPTT in Platelet poor plasma by Coagulation assay
117
568
2.33
13.66
2.6
2.2
s
30.1
29.4
0.66
117
547
(3000570) Elastase.pancreatic [Mass/mass] in Stool
37
93
4.19
13.56
1.6
1.3
ug/g
274.3
309.0
0.37
20
51
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
435
3422
2.16
13.51
4.7
3.7
pmol/l
15.0
14.7
1.41
394
3061
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
46
136
3.59
13.45
14.5
8.7
mmol/l
24.6
23.4
1.32
41
129
(40768806) Pleura Pathology biopsy report
13
10
13.28
13.41
1.8
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
38
99
4.04
13.28
4.3
3.6
u/ml
0.4
0.4
0.17
26
60
(3021447) Carbon dioxide [Partial pressure] in Venous blood
79
329
2.63
12.79
5.2
3.0
kpa
5.8
5.6
0.48
71
319
(3004451) EKG impression Narrative
13
11
12.07
12.67
1.8
1.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
26
52
5.19
12.53
1.2
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
14
14
10.23
12.28
1.7
1.9
—
—
—
0
0
(3015736) pH of Urine
247
1644
1.89
12.05
3.6
3.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
384
2952
1.93
11.83
3.6
2.8
u/l
61.1
46.3
1.66
356
2756
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
33
85
4.06
11.71
1.2
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
30
72
4.34
11.67
3.2
2.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
23
44
5.41
11.63
1.2
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
16
21
7.81
11.47
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
16
21
7.81
11.47
1.1
1.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
467
3867
2.17
11.35
32.5
12.7
%
14.0
13.6
7.69
462
3777
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
24
50
4.97
11.05
1.0
1.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
79
353
2.44
10.99
10.4
6.0
mmol/l
0.9
0.4
0.39
55
270
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
32
85
3.93
10.90
1.3
1.9
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
152
885
1.98
10.89
1.8
1.7
pmol/l
121849145.5
44993568.5
0.27
119
729
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
248
1692
1.83
10.88
4.8
3.4
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
33
91
3.79
10.67
1.2
1.2
u/ml
52.2
56.8
—
5
8
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
16
23
7.13
10.62
1.2
1.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
16
23
7.13
10.62
1.2
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
16
23
7.13
10.62
1.2
1.0
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
77
349
2.40
10.37
10.7
6.0
kpa
11.6
13.6
4.16
71
338
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
77
349
2.40
10.37
10.8
6.0
kpa
5.0
5.0
0.04
71
338
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
30
79
3.95
10.34
1.3
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
188
1192
1.86
10.33
3.0
2.8
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
16
24
6.83
10.23
1.2
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
16
24
6.83
10.23
1.2
1.0
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
16
24
6.83
10.23
1.2
1.0
—
—
—
0
0
(3036489) Thrombin time
43
145
3.13
10.23
2.2
2.4
s
23.0
21.0
0.82
36
129
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
11
10
11.20
10.19
1.5
1.3
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
11
10
11.20
10.19
1.5
1.3
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
11
10
11.20
10.19
1.5
1.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
11
10
11.20
10.19
1.5
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
14
18
7.95
10.18
1.2
1.7
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
15
21
7.31
10.18
1.5
1.2
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
18
31
5.96
10.12
1.6
1.6
%
31.3
25.3
0.21
11
25
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
17
28
6.23
9.97
1.1
1.0
u/ml
0.1
0.2
—
5
6
(3006922) Hepatitis E virus Ab [Presence] in Serum
15
22
6.98
9.77
1.1
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
17
29
6.01
9.64
1.0
1.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
70
314
2.40
9.63
1.1
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
205
1359
1.80
9.61
3.4
3.2
mmol/l
7.2
7.8
1.14
166
1135
(3019309) Folate [Moles/volume] in Red Blood Cells
125
709
1.98
9.52
2.0
1.7
nmol/l
1093.8
1142.2
0.25
94
536
(3024354) Oxygen [Partial pressure] in Venous blood
65
284
2.46
9.47
3.3
2.9
kpa
4.5
4.5
0.09
58
277
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
56
229
2.60
9.36
2.6
3.5
pmol/l
4.6
4.6
0.01
45
202
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
26
67
4.02
9.23
1.2
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
14
9
15.90
9.07
4.4
2.8
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
42
150
2.94
9.06
2.4
3.5
g/l
0.2
0.3
0.14
24
60
(40768804) Tissue Pathology biopsy report
236
1654
1.73
8.98
2.4
2.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
189
1244
1.78
8.96
3.4
3.3
mg/l
670.9
207.8
0.56
128
775
(3004616) Nuclear Ab [Presence] in Serum
20
43
4.78
8.88
1.5
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
13
18
7.37
8.88
5.1
3.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
13
18
7.37
8.88
1.5
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
13
18
7.37
8.88
1.5
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
13
18
7.37
8.88
1.5
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
15
25
6.14
8.69
1.5
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
15
25
6.14
8.69
1.3
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
13
8
16.58
8.58
1.1
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
14
22
6.50
8.56
1.9
1.9
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
14
22
6.50
8.56
1.3
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
241
1718
1.70
8.49
2.1
1.9
pmol/l
96.7
94.8
0.19
133
870
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
124
728
1.90
8.45
2.9
2.6
mmol/l
2.5
2.4
0.19
106
640
(3035637) Corticotropin [Mass/volume] in Plasma
19
41
4.76
8.40
1.6
1.9
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
32
102
3.26
8.36
5.1
2.7
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
8
0
+∞
8.35
1.1
0.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
49
200
2.59
8.23
3.7
4.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
23
59
4.02
8.22
1.7
1.8
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
525
4714
2.50
8.09
28.8
12.3
mmol/l
4.0
4.0
0.21
518
4560
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
479
4155
1.98
8.06
5.7
4.3
mu/l
1.9
1.9
0.08
449
3762
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
11
14
7.99
8.01
1.4
1.6
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
11
14
7.99
8.01
1.4
1.6
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
16
31
5.28
7.97
1.1
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
11
6
18.66
7.62
1.1
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
10
12
8.46
7.60
1.7
1.3
—
—
—
0
0
(44790048)
11
15
7.46
7.57
1.3
1.2
—
—
—
0
0
(44790047)
11
15
7.46
7.57
1.3
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
11
15
7.46
7.57
1.4
1.5
—
—
—
0
0
(44806118)
11
15
7.46
7.57
1.3
1.2
—
—
—
0
0
(44790049)
11
15
7.46
7.57
1.3
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
11
15
7.46
7.57
1.4
1.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
151
972
1.75
7.54
1.8
1.5
nmol/l
17.8
21.0
1.89
135
814
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
19
45
4.33
7.53
1.7
1.9
%
51.8
64.1
0.56
13
35
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
341
2717
1.64
7.43
3.4
2.8
—
—
—
0
0
(3048879) Bone marrow aspiration report
12
9
13.59
7.41
1.6
1.8
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
56
256
2.32
7.38
5.8
4.1
ng/l
117.6
83.1
1.79
50
228
(3044889) 12 lead EKG panel
383
3147
1.67
7.34
5.6
3.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
67
331
2.16
7.33
2.7
2.0
u/l
30.0
175.6
0.51
61
284
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
489
4311
1.97
7.27
24.5
9.8
ml/min/173m2
78.7
81.5
1.78
443
3471
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
11
7
15.98
7.25
1.8
2.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
52
234
2.35
7.10
2.9
2.5
e9/l
4.4
3.6
2.24
44
190
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
33
119
2.88
7.02
2.3
1.7
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
19
48
4.06
6.94
1.6
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
19
48
4.06
6.94
1.6
1.4
—
—
—
0
0
(3013512) EKG study
176
1206
1.67
6.91
4.9
3.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
17
40
4.35
6.79
1.2
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
19
49
3.98
6.76
1.6
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
19
49
3.98
6.76
1.6
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
19
49
3.98
6.76
1.6
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
19
49
3.98
6.76
1.6
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
189
1327
1.64
6.71
4.6
4.0
mg/mmol
16.2
6.6
1.05
124
820
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
12
21
5.82
6.61
1.6
1.7
u/l
10.3
5.8
—
6
8
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
42
178
2.47
6.55
1.8
1.6
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
14
29
4.92
6.48
1.1
1.4
ug/l
37.9
21.0
0.35
14
29
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
26
88
3.05
6.19
1.2
1.4
mg/l
487.2
512.2
0.14
26
82
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
39
164
2.48
6.19
17.5
8.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
110
681
1.76
6.19
3.1
2.5
e6/l
0.6
1.3
2.17
67
387
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
45
203
2.32
6.13
1.6
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
10
8
12.69
6.10
1.6
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
25
84
3.07
6.03
1.6
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
14
31
4.60
6.01
5.6
3.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
18
49
3.76
5.96
1.1
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
16
40
4.09
5.93
1.2
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
10
9
11.28
5.81
1.4
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
13
28
4.73
5.76
1.1
1.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
45
209
2.25
5.74
1.2
1.1
—
34.0
—
0
5
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
15
37
4.14
5.66
1.2
1.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
45
211
2.23
5.61
1.4
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
21
67
3.22
5.52
1.3
1.1
u/ml
2.1
5.8
—
7
20
(4306422)
20
62
3.31
5.50
1.3
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
15
38
4.03
5.47
1.2
1.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
26
95
2.82
5.44
1.3
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
28
107
2.70
5.39
2.0
1.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
100
627
1.72
5.34
3.3
2.6
e6/l
1.8
2.0
0.16
57
339
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
104
661
1.70
5.29
1.6
1.4
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
35
151
2.40
5.28
1.1
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
16
44
3.71
5.24
1.2
1.2
nmol/l
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
10
19
5.34
5.05
2.4
1.3
u/l
213.1
190.4
—
10
19
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
9
9
10.14
5.04
1.4
1.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
9
9
10.14
5.04
1.4
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
16
46
3.55
4.92
1.1
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
12
28
4.36
4.84
1.6
2.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
257
2047
1.47
4.75
5.4
3.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
13
33
4.01
4.73
1.1
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
22
80
2.82
4.66
1.4
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
17
53
3.28
4.65
1.2
1.5
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
20
69
2.97
4.64
1.3
1.1
u/ml
4.2
4.6
—
9
25
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
58
322
1.89
4.62
2.6
2.2
ug/l
20.3
7.6
0.47
52
291
(3022313) Gas panel - Capillary blood
31
135
2.37
4.61
4.7
3.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
5
14.15
4.58
1.3
1.0
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
7
5
14.15
4.58
1.7
2.2
%
4.1
5.0
—
7
5
(21494814) CD8 cells/100 lymphocytes in Specimen
7
5
14.15
4.58
1.7
2.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
48
254
1.97
4.41
1.2
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
528
4934
2.00
4.40
17.4
8.6
u/l
25.8
26.5
0.44
521
4734
(4027681)
11
26
4.29
4.37
1.4
1.3
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
9
12
7.60
4.37
1.3
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
14
40
3.56
4.35
1.1
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
10
22
4.61
4.32
1.1
1.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
31
142
2.25
4.13
2.5
2.4
u/l
3706.2
2326.9
—
10
59
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
38
190
2.07
4.08
2.2
2.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
13
37
3.57
4.07
1.2
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
173
1310
1.46
4.01
3.4
2.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
517
4827
1.79
3.91
23.3
10.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
18
65
2.83
3.89
1.3
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
20
77
2.66
3.84
1.3
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
18
66
2.78
3.79
1.3
1.0
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
7
8
8.84
3.78
1.0
1.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
13
39
3.39
3.78
2.4
2.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
19
72
2.70
3.76
3.7
2.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
66
411
1.69
3.61
1.5
1.7
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
9
17
5.36
3.52
1.2
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
9
17
5.36
3.52
1.1
2.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
9
17
5.36
3.52
1.1
2.4
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
17
63
2.75
3.52
4.1
1.5
%
61.9
61.1
0.05
17
63
(3022217) INR in Platelet poor plasma by Coagulation assay
75
488
1.62
3.47
18.4
23.4
inr
1.0
1.3
3.62
12
67
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
160
1224
1.43
3.45
1.9
1.6
mmol/l
1.5
1.3
1.40
120
1015
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
50
292
1.78
3.43
1.3
1.2
iu/ml
96.3
148.9
0.48
19
118
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
9
18
5.06
3.38
1.1
1.1
—
—
—
0
0
(3020891) Body temperature
29
141
2.11
3.38
3.1
4.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
461
4229
1.48
3.29
6.6
5.4
mmol/mol
40.8
39.2
2.35
424
3894
(4268621)
12
38
3.20
3.23
2.8
2.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
28
3.62
3.21
1.6
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
7
11
6.43
3.19
1.4
1.2
—
—
—
0
0
(3019225) pH of Specimen
60
378
1.66
3.16
6.5
4.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
24
112
2.19
3.11
2.3
2.5
—
—
—
0
0
(3002256) Pathology report gross observation
80
543
1.55
3.11
1.4
1.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
8
7.56
3.06
1.2
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
23
107
2.20
3.00
1.4
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
23
108
2.18
2.94
1.4
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
46
2.87
2.93
1.4
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
10
30
3.38
2.92
2.4
2.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
23
109
2.16
2.88
1.4
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
11
36
3.10
2.82
1.3
1.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
14
5.05
2.73
2.6
2.9
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
7
14
5.05
2.73
1.7
1.4
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
6
10
6.05
2.70
1.3
2.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
75
521
1.51
2.63
1.5
1.7
%
1.6
1.4
2.09
68
472
(1761868) Lipid panel - Serum or Plasma
208
1725
1.32
2.60
3.4
2.7
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
8
20
4.04
2.57
1.3
1.1
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
8
20
4.04
2.57
2.1
2.6
nmol/l
76.5
71.0
—
8
20
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
7
7.19
2.55
1.4
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
7
7.19
2.55
1.4
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
7
7.19
2.55
1.4
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
5
7
7.19
2.55
1.4
1.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
50
2.64
2.54
1.2
1.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
30
165
1.86
2.54
2.4
2.0
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
18
82
2.23
2.50
1.6
1.7
e6/l
18969.8
18882.8
0.00
13
65
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
11
39
2.86
2.49
2.4
3.0
nmol/l
3.4
3.2
0.05
11
39
(3000764) Benzodiazepines [Presence] in Urine
30
167
1.84
2.45
2.4
2.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
453
4207
1.38
2.45
28.4
11.3
%
39.2
40.1
1.26
321
3045
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
59
397
1.54
2.41
1.5
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
30
169
1.82
2.37
2.4
2.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
30
169
1.82
2.37
2.4
2.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
12
46
2.64
2.37
1.5
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
51
335
1.57
2.31
3.3
2.6
ml/min/173m2
51.2
66.8
2.32
25
140
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
15
67
2.27
2.19
1.5
1.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
540
5212
1.73
2.16
40.3
15.8
e9/l
270.2
246.6
12.46
534
5062
(1001926) Buprenorphine [Presence] in Urine by Screen method
24
131
1.87
2.11
2.0
2.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
540
5217
1.71
2.08
40.2
15.8
e12/l
4.4
4.5
5.34
534
5049
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
10
5.03
2.07
1.0
1.7
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
10
5.03
2.07
1.2
1.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
540
5218
1.71
2.06
40.3
15.8
e9/l
7.9
6.5
22.01
534
5048
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
7
20
3.53
2.06
1.1
1.1
iu/ml
314.4
194.4
—
7
20
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
60
421
1.48
2.04
3.4
4.0
ug/l
108.2
37.0
0.33
49
342
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
9
32
2.84
2.01
1.3
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
25
141
1.81
2.00
1.2
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
15
70
2.17
2.00
2.5
3.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
11
4.58
1.94
5.6
1.8
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
20
108
1.88
1.84
3.0
2.3
ug/min
308.2
62.2
0.51
13
62
(3016879) Cocaine [Presence] in Urine
26
153
1.73
1.83
2.6
2.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
12
4.19
1.82
1.2
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
9
35
2.60
1.80
1.3
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
47
2.37
1.78
1.4
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
11
47
2.37
1.78
1.5
2.5
umol/l
5.3
6.1
—
5
38
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
18
3.36
1.75
1.2
1.1
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
6
18
3.36
1.75
1.2
1.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
9
36
2.52
1.74
1.3
1.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
28
171
1.67
1.74
1.6
1.4
iu/l
26.9
29.1
0.10
19
148
(3003740) Influenza virus B Ag [Presence] in Specimen
14
68
2.09
1.71
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
14
68
2.09
1.71
1.2
1.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
14
68
2.09
1.71
2.6
3.0
nmol/l
0.6
0.9
—
9
55
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
29
451
0.62
1.71
2.0
1.7
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
24
141
1.73
1.71
1.7
1.4
mu/l
465.9
291.7
0.92
19
128
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
473
4492
1.32
1.67
5.2
4.3
mmol/l
6.0
5.9
0.72
432
4059
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
121
985
1.29
1.67
4.0
2.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
19
3.18
1.66
1.0
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
7
25
2.82
1.65
2.9
1.8
%
8.5
10.3
—
7
25
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
14
3.59
1.62
1.2
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
14
3.59
1.62
1.8
1.1
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
6
20
3.02
1.58
4.8
6.9
u/ml
—
60.8
—
0
5
(21491868) Cryoglobulin [Mass/volume] in Serum
6
20
3.02
1.58
1.0
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
15
3.35
1.52
1.4
1.3
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
6
21
2.88
1.51
19.0
20.6
nmol/l
1838.3
1744.6
—
6
21
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
31
203
1.56
1.49
1.5
1.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
15
80
1.90
1.46
1.2
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
28
2.52
1.45
1.7
1.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
5
16
3.14
1.44
1.0
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
6
139
0.43
1.41
2.0
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
14
74
1.91
1.40
1.0
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
487
4671
1.30
1.38
5.4
4.8
mmol/l
2.7
2.8
1.44
449
4291
(3022621) pH of Urine by Test strip
39
274
1.45
1.37
1.9
2.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
23
2.63
1.37
1.2
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
17
2.96
1.36
1.6
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
21
129
1.65
1.31
1.5
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
31
210
1.50
1.30
1.0
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
478
4584
1.27
1.28
5.0
4.3
mmol/l
4.6
4.7
1.19
442
4238
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
19
2.65
1.22
8.6
2.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
32
449
0.70
1.20
1.2
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
57
442
1.32
1.15
2.2
1.9
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
35
251
1.42
1.13
1.5
2.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
31
218
1.45
1.11
1.6
1.6
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
31
2.27
1.10
1.3
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
27
185
1.48
1.10
1.6
1.9
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
5
21
2.39
1.09
1.4
3.9
mu/l
28.5
19.7
—
5
21
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
22
2.28
1.03
1.2
1.2
miu/ml
2388.0
1752.2
—
5
22
(3004716) Salmonella sp identified in Stool by Organism specific culture
30
214
1.42
1.02
1.4
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
61
491
1.27
0.96
2.3
2.0
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
6
29
2.08
0.89
1.7
1.7
mmol/l
6.3
6.8
—
6
18
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
44
555
0.78
0.86
5.6
4.4
%
30.0
31.6
0.44
31
367
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
13
80
1.64
0.85
1.6
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
146
1304
1.16
0.81
1.5
1.4
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
33
1.83
0.79
1.2
1.5
g/l
0.8
1.0
—
6
33
(4034850)
10
158
0.63
0.71
11.8
9.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
15
215
0.69
0.69
1.5
1.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
108
956
1.16
0.68
4.3
3.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
469
4560
1.16
0.68
5.0
4.3
mmol/l
1.4
1.5
1.69
433
4191
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
44
535
0.81
0.66
6.1
6.8
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
24
314
0.75
0.65
1.8
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
452
4402
1.13
0.55
4.5
3.9
mmol/l
1.4
1.3
3.26
414
4028
(3018405) Lactate [Moles/volume] in Arterial blood
17
125
1.37
0.54
3.4
3.8
mmol/l
1.4
1.3
0.09
17
125
(1002224) Polysomnography panel
22
171
1.30
0.50
1.1
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
22
172
1.29
0.49
2.2
2.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
11
76
1.46
0.48
1.7
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
13
94
1.39
0.46
1.5
1.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
32
1.57
0.42
1.4
1.6
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
13
96
1.36
0.42
2.2
1.7
iu/l
12.5
5.9
—
6
34
(4094501)
16
123
1.31
0.41
1.1
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(4024509)
5
35
1.43
0.39
1.4
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
17
133
1.29
0.39
1.7
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
44
1.37
0.34
1.3
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
74
675
1.11
0.33
1.5
1.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
12
92
1.31
0.32
1.4
1.7
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
12
92
1.31
0.32
1.9
1.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
55
1.28
0.30
1.1
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
13
162
0.80
0.28
1.5
1.8
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
39
346
1.14
0.28
2.3
2.2
nmol/l
11.7
12.9
0.38
32
312
(3051387) C reactive protein [Mass/volume] in Capillary blood
11
87
1.27
0.24
3.0
3.1
mg/l
24.6
27.2
—
5
51
(3051101) Glucose [Moles/volume] in Cord blood
0
11
0.00
0.21
0.0
6.1
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
10
0.00
0.21
0.0
4.7
—
—
—
0
0
(44806420)
0
12
0.00
0.21
0.0
2.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
11
89
1.24
0.21
1.3
1.4
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
80
1.25
0.20
1.0
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
12
99
1.22
0.19
1.8
1.7
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
51
1.18
0.19
1.7
1.6
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
6
51
1.18
0.19
2.3
1.3
ug/l
2.0
3.3
—
6
44
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
19
165
1.16
0.19
2.6
2.8
u/ml
68.2
1055.3
0.63
14
143
(3014051) Protein [Presence] in Urine by Test strip
11
90
1.23
0.19
2.2
2.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
166
1603
1.05
0.19
5.1
5.1
ug/l
9.6
2.7
0.47
153
1433
(1761482) Bacteria [#/volume] in Urine by Culture
10
120
0.83
0.16
4.3
4.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
73
1.10
0.15
1.9
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
99
959
1.04
0.10
4.7
3.8
kg/l
1.0
1.0
—
10
127
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
10
87
1.15
0.09
2.2
1.8
pmol/l
191.0
207.7
—
10
79
(40768800) Prostate Pathology biopsy report
10
108
0.92
0.03
1.1
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
97
958
1.02
0.02
2.7
3.0
ug/l
0.8
0.8
0.07
67
640
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
130
1311
0.99
0.02
3.9
4.4
%
22.3
21.4
0.31
66
647
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
19
196
0.97
0.00
1.7
2.7
u/ml
18.6
48.6
0.89
19
190
(40761535) Cells panel - Urine sediment
35
356
0.98
0.00
5.3
3.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
50
506
0.99
0.00
2.0
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
12
125
0.96
0.00
1.6
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
21
213
0.99
0.00
4.0
3.5
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
1.0
—
0.4
—
0
5
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
17.3
—
0
6
(40758358) Immune stain study
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
9
0.00
0.00
0.0
4.2
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
6
0.00
0.00
0.0
1.0
—
4.6
—
0
6
(3017509) Phencyclidine [Presence] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
9
0.00
0.00
0.0
8.4
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
6
0.00
0.00
0.0
3.5
—
671.8
—
0
6
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint ESOSINOPHIL_DISEASE and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| ESOSINOPHIL_DISEASE | 1.584 [1.31, 1.92] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.321 |
During the follow-up period (1.1.1998 — 31.12.2019), 216 out of 1475 females with ESOSINOPHIL_DISEASE died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| ESOSINOPHIL_DISEASE | 1.733 [1.41, 2.13] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.006 |
During the follow-up period (1.1.1998 — 31.12.2019), 271 out of 1353 males with ESOSINOPHIL_DISEASE died.
Mortality risk
Mortality risk for people of age
years, who have ESOSINOPHIL_DISEASE.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.158% | 0.352% |
| 5 | 1.08% | 1.952% |
| 10 | 2.6% | 4.925% |
| 15 | 4.718% | 9.169% |
| 20 | 8.017% | 15.241% |
Relationships between endpoints
↥Index endpoint: ESOSINOPHIL_DISEASE – Eosinophilic disease (BM)
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data